Aspen Aerogels (NYSE: ASPN) reported Q4 EPS of ($0.12), $0.02 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $28 million versus the consensus estimate of $25.9 million.

For earnings history and earnings-related data on Aspen Aerogels (ASPN) click here.